PHAT - Phathom Pharmaceuticals reports Q3 results November, 08 2021 08:49 AM Phathom Pharmaceuticals Inc. Phathom Pharmaceuticals (NASDAQ:PHAT): Q3 GAAP EPS of -$0.98 beats by $0.03. Cash and cash equivalents were of $224M Press Release For further details see: Phathom Pharmaceuticals reports Q3 results